Lunula Laser® is the revolutionary low-level laser therapy bringing new hope to people suffering from the painful, discolored and disfigured toenails associated with onychomycosis, or nail fungus. Lunula Laser® promises no pain, no risk and no downtime and is the easy, convenient way to experience healthy, clear nails again.

The Lunula Laser® targets fungus that lives in and under the toenail. The laser light passes through the nail without causing damage to it or the surrounding skin. Effective, the Lunula Laser® poses none of the risk and harmful side effects of oral anti-fungal medications. Plus, this convenient in-office procedure typically takes only minutes to perform, with absolutely no recovery time required. Stop suffering the pain and embarrassment of unsightly nail fungus, and enjoy clear, beautiful nails today.

Erchonia’s Lunula Laser FAQ

  • Is the laser FDA approved?
    Yes. Erchonia submitted the results of their successful clinical trial and the laser was granted market clearance by the FDA in June 2016 for the temporary increase of clear nail in patients with onychomycosis.

  • What are the advantages of the Erchonia Lunula onychomycosis laser device?
    This device is unique in that it is the only true, dual diode, non-thermal, unattended Class 2 laser that offers multiple benefits. The Lunula combines the anti-fungal effects of the 405 nm wavelength with the cellular function impact of a 635 nm wavelength. The Lunula produces two wavelengths, 635 nm and 405 nm, both of which have been enriched by a proprietary rotating line-generated laser beam. The Lunula’s specially designed delivery mechanism maximizes both photon concentration and treatment surface area. The Lunula’s patented delivery system ensures that all infected tissue, nail bed and most importantly, the proximal germinal/matrix tissue are properly targeted and treated.

  • Are all laser wavelengths the same?
    No. The higher wavelengths have less energy and normally more power is added which produces heat. Normally output power of watts and wavelengths of 900nm or higher are considered Class IV devices and produce an increase in temperature in the tissue being treated. The lower wavelength lasers, Class 2, Class 3A and 3B depending on power output, do not rely on heat production. Cold lasers initiate true physiologic responses, photo modulation. The Class2/3A/3B lasers have wavelengths 700 nm or lower.

  • Can I feel the laser working?
    The patient will feel no heat or any sensation from the laser.

  • What is the advantage utilizing a multiple diode approach in the treatment of onychomycosis?
    The 635 nm wavelength stimulates endogenous mechanisms, which enhances the immunological function of resident neutrophil and macrophage function to further degrade the infectious agent. This wavelength also induces tissue rejuvenation, increased vascularization, which enables the dual diode approach to accelerate the growth of new clear nail growth. The 405 nm wavelength provides anti-microbial, antibacterial and anti-fungal effects. The patented dual diode approach provided by the Lunula Onychomycosis Device provides symbiotic wavelengths that enhance new clear nail growth at 6 months.

  • What kind of response has been seen when utilizing the dual diode lower wavelength approach in the treatment of onychomycosis?
    In the clinical trial results 89% of patients respond.

  • Are there any complications with Lunula Laser therapy?
    No complications were reported in all 4 Lunula Laser clinical trials.

  • Is it recommended to obtain fungal cultures prior to low-level laser therapy?
    During the Lunula clinical trial, a positive mycology study was received on all patients.

  • Is debridement of the toenail necessary when utilizing laser therapy to treat onychomycosis?
    No. During the Lunula studies, no debridement was performed.

  • What are the Advantages of Lunula Low Level Laser for the Treatment of
    Onychomycosis?
    • no chance of developing microbial resistance to this form of treatment
    • does not interfere nor interact with any systemic medicine
    • no chance for liver toxicity
    • treatment protocol is painless, ensuring good patient compliance
    • no pain during treatment
    • no downtime
    • unattended treatment

  • How does the LunulaLaser work?
    Peroxynitrite is a compound that has potent anti-microbial effects. This compound is formed when Nitric Oxide (NO) reacts with Reactive Oxygen Species (ROS). The Lunula Laser by Erchonia, the only true Low Level Laser used to treat onychomycosis, uniquely has two different laser diodes; a 635nm and a 405nm. This combination of wavelengths is crucial in that the 635nm diode produces NO and the 405nm diode is the best producer of ROS, both within the visible light spectrum. Cell destruction is triggered by the cytotoxic effects of peroxynitrite.
    *NO + ROS = peroxynitrite which destroys fungal pathogens*
    The 635nm laser enhances mitochondrial energy metabolism, which generates NO, and this is combined with the 405nm laser, which generates ROS, produces peroxynitrite. This by-product is cytotoxic and destroys pathogenic bacteria, fungi and protozoa.

  • Can a patient become re-infected with fungus once there is clearance?
    Yes, patients can become re-infected if they do not take precautions. If a spouse or significant other has clinical nail fungus, it is advised to not treat them without treating their partner. It is recommended for patients to take other precautions to prevent re-infection. Recommendations include, using a gas sterilizer to treat their shoes, using anti-fungal spray to use after wearing closed toe shoes and spraying their showers with Tylex or other cleanser, all with the hope of preventing re-infection.

  • What kind of clinical results are experienced with the Lunula Laser?
    Clinical trial results proved an average of 6.1 mm New Clear Nail Growth at 6 Months.